| Wilfredo Villafane, RPH | |
|
3535 Ave Militar Ste 193, Plaza Isabela, Isabela, PR 00662-4046 | |
| (787) 830-3004 | |
| (787) 830-3474 |
| Full Name | Wilfredo Villafane |
|---|---|
| Gender | Male |
| Speciality | Pharmacist |
| Location | 3535 Ave Militar Ste 193, Isabela, Puerto Rico |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1336524362 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 3918 (Puerto Rico) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Wilfredo Villafane, RPH 3535 Ave Militar Ste 193, Plaza Isabela, Isabela, PR 00662-4046 Ph: (787) 830-3004 | Wilfredo Villafane, RPH 3535 Ave Militar Ste 193, Plaza Isabela, Isabela, PR 00662-4046 Ph: (787) 830-3004 |
News Archive
Nearly 500 researchers, clinicians and mental health advocates are expected to attend the 2010 Marc- Society International Conference, Perinatal Mental Health Research: Harvesting the Potential, Oct. 26 to 30, at the Sheraton Station Square Hotel in Pittsburgh. The event, which focuses on women's mental health issues related to childbearing, will feature keynote speaker former First Lady Rosalynn Carter, who has been an active advocate for mental health reform.
Johnson & Johnson Pharmaceutical Research and Development, L.L.C. (J&JPRD), announced today that results from the Phase III EINSTEIN-Extension (EXT) clinical trial of the novel oral anticoagulant rivaroxaban showed a significant reduction in the risk of recurrent symptomatic venous thromboembolism (VTE), compared to placebo, in patients who have been treated for a previous deep vein thrombosis (DVT) or pulmonary embolism (PE).
Writing in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, Joe Cerrell, director of the foundation's Europe office, and David Ferreira, managing director for innovative finance and head of the Washington, D.C., office at the GAVI Alliance, examine the benefits of investing in vaccines, stating, "Funding and supporting the delivery of life-saving vaccines is one proven way that the private sector can obtain measurable, long-term, and extremely cost-effective results."
The new drug sotorasib reduces tumor size and shows promise in improving survival among patients with lung tumors caused by a specific DNA mutation, according to results of a global phase 2 clinical trial.
› Verified 1 days ago
Mrs. Saudhi E Morales, RPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 89 Calle Manuel Corchado Juarbe, Isabela, PR 00662 Phone: 787-872-4777 Fax: 787-872-4777 | |
Noemi Erba, BSPH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Avenida Miltar 2981, Isabela, PR 00662 Phone: 787-830-3189 Fax: 787-830-1573 | |
Patricia Elena Delgado, PHARMD. Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 9 Calle Barbosa, Isabela, PR 00662 Phone: 787-872-2560 Fax: 787-872-2560 | |
Mr. Emilio E Sanz, PH Pharmacist Medicare: Not Enrolled in Medicare Practice Location: Ave Agustin Ramos Calero Int 111, Isabela, PR 00662 Phone: 787-830-2705 Fax: 787-830-0465 | |
Javier Lopez Mendez, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 7032 Ave Agustin Ramos Calero, Isabela, PR 00662 Phone: 787-429-5905 | |
Kelvin D Cruz Roman, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3480 Ave Militar, Isabela, PR 00662 Phone: 787-872-0502 |